Publication | Closed Access

Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration

Ocular DiseaseVitreous BodyOphthalmologyAge-related DiseasesGlaucomaMedicineIntravitreal Bevacizumab